Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use (ACCESS)

NCT04112095 is registered in ClinicalTrials.gov with HRA Pharma as lead sponsor.

NCT NCT04112095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04112095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use (ACCESS)
Lead sponsor
HRA Pharma
Phase
Phase 3
Overall status
Completed
Start date
September 6, 2019
Completion date
August 5, 2021
Enrollment
962 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

contraception